Literature DB >> 6798568

Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells.

H K Ziegler, E R Unanue.   

Abstract

This paper describes the effects of two lysosomotropic compounds, ammonia and chloroquine, on the interaction of mononuclear phagocytes with immune T cells. The uptake and ingestion of Listeria monocytogenes by macrophages were not affected by the drugs; however, the macrophage catabolism of 125I-labeled Listeria was reduced in a dose-dependent way. The macrophage presentation of Listeria to T cells, an I-region-dependent phenomenon, was also inhibited. The degree of inhibition of catabolism paralleled that of antigen presentation. The inhibition of antigen presentation took place if the macrophages were treated before and during Listeria uptake; minimal inhibition took place if the macrophages were treated 30 min after Listeria ingestion, at which time a significant amount of bacteria was already catabolized. Our previous studies had shown that the macrophage-associated antigen recognized by T cells became apparent 30-60 min after uptake of Listeria. We conclude that ammonia and chloroquine affected an intracellular handling step required for the expression of the immunogen relevant for T-cell recognition.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6798568      PMCID: PMC345685          DOI: 10.1073/pnas.79.1.175

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Nature of T lymphocyte recognition of macrophage-associated antigens. II. Macrophage determination of guinea pig T cell responses to human fibrinopeptide B.

Authors:  D W Thomas; S K Meltz; G D Wilner
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

2.  Induction of cytocidal macrophages after in vitro interactions between Listeria-immune T cells and macrophages--role of H-2.

Authors:  A G Farr; W J Wechter; J M Kiely; E R Unanue
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

3.  Studies on hypersensitivity. II. Delayed hypersensitivity to denatured proteins in guinea pigs.

Authors:  P G GELL; B BENACERRAF
Journal:  Immunology       Date:  1959-01       Impact factor: 7.397

4.  Cellular and humoral immunity: a distinction in antigenic recognition.

Authors:  K Thompson; M Harris; E Benjamini; G Mitchell; M Noble
Journal:  Nat New Biol       Date:  1972-07-05

5.  Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents.

Authors:  S Ohkuma; B Poole
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

Review 6.  Commentary. Lysosomotropic agents.

Authors:  C de Duve; T de Barsy; B Poole; A Trouet; P Tulkens; F Van Hoof
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

7.  Nature of T lymphocyte recognition of macrophage-associated antigens. I. Response of guinea pig T cells to human fibrinopeptide B.

Authors:  D W Thomas; S K Meltz; G D Wilner
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

Review 8.  Regulation of the immune response--role of the macrophage.

Authors:  A S Rosenthal
Journal:  N Engl J Med       Date:  1980-11-13       Impact factor: 91.245

Review 9.  The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

10.  Is genetically related macrophage factor (GRF) a soluble immune response (Ir) gene product?

Authors:  P Erb; B Meier; M Feldmann
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

View more
  179 in total

1.  Recycling MHC class I molecules and endosomal peptide loading.

Authors:  M Grommé; F G Uytdehaag; H Janssen; J Calafat; R S van Binnendijk; M J Kenter; A Tulp; D Verwoerd; J Neefjes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

Review 2.  Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

3.  Urease activity may contribute to the ability of Actinobacillus pleuropneumoniae to establish infection.

Authors:  J T Bossé; J I MacInnes
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

Review 4.  Cutaneous graft-versus-host disease--clinical considerations and management.

Authors:  Peggy A Wu; Edward W Cowen
Journal:  Curr Probl Dermatol       Date:  2012-02-17

5.  Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking.

Authors:  Raffaella Pierleoni; Michele Menotta; Antonella Antonelli; Carla Sfara; Giordano Serafini; Sabrina Dominici; Maria Elena Laguardia; Annalisa Salis; Gianluca Damonte; Lucia Banci; Marco Porcu; Paolo Monini; Barbara Ensoli; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2010-08-20       Impact factor: 3.396

6.  Kinetics of antigenic peptide binding to the class II major histocompatibility molecule I-Ad.

Authors:  R Tampé; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

Review 7.  Eosinophils in innate immunity: an evolving story.

Authors:  Revital Shamri; Jason J Xenakis; Lisa A Spencer
Journal:  Cell Tissue Res       Date:  2010-11-03       Impact factor: 5.249

Review 8.  Cellular mechanisms of antigen processing and the function of class I and II major histocompatibility complex molecules.

Authors:  C V Harding; E R Unanue
Journal:  Cell Regul       Date:  1990-06

Review 9.  The elucidation of non-classical MHC class II antigen processing through the study of viral antigens.

Authors:  Asha Purnima Veerappan Ganesan; Laurence C Eisenlohr
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

Review 10.  Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.

Authors:  Babafemi Taiwo; Luis Barcena; Randall Tressler
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.